logo_no_tag_2c.jpg
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
September 06, 2022 16:30 ET | Sientra, Inc.
SANTA BARBARA, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced...
logo_no_tag_2c.jpg
Sientra Reports Second Quarter Revenue Growth Driven By Increased Acceleration in Reconstruction Channel
August 11, 2022 16:05 ET | Sientra, Inc.
SANTA BARBARA, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of...
logo_no_tag_2c.jpg
Sientra to Report Second Quarter 2022 Financial Results on August 11, 2022
July 28, 2022 08:30 ET | Sientra, Inc.
SANTA BARBARA, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of...
logo_no_tag_2c.jpg
Sientra Wins Premier’s Horizon Award for 2022 for Exceptional Customer Service, Engagement, and Value Creation
July 11, 2022 09:00 ET | Sientra, Inc.
SANTA BARBARA, Calif., July 11, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a leading medical aesthetics company focused on enhancing lives by advancing the...
logo_no_tag_2c.jpg
FDA Approves Sientra’s Low Plus Profile Projection Breast Implant
July 06, 2022 09:00 ET | Sientra, Inc.
SANTA BARBARA, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”) announced today that the U.S. Food and Drug Administration (FDA) approved the Low...
Colorescience All Calm® Sensitive Skin Regimen
NEW CLINICAL STUDY DEMONSTRATES COLORESCIENCE ALL CALM® REGIMEN NEUTRALIZES REDNESS AND CALMS INFLAMED SKIN
June 29, 2022 08:30 ET | Colorescience
Carlsbad, CA, June 29, 2022 (GLOBE NEWSWIRE) -- Colorescience®, a leading dermatologist-recommended specialty skincare and cosmetics company announces published results in the Journal of Cosmetic...
Featured Image for Empire Medical Training
Empire Medical Training Introduces Latest Aesthetic Combination Course at the Aesthetic Show in Las Vegas
June 22, 2022 09:00 ET | Empire Medical Training
FORT LAUDERDALE, Fla., June 22, 2022 (GLOBE NEWSWIRE) -- The future of aesthetics is here. Empire Medical Training, the industry leader in providing accredited continuing medical education (CME),...
COLORESCIENCE® REVEALS CLINICAL STUDY RESULTS OF THE FINISHING TOUCH™ SKINCARE PROTOCOL FOLLOWING FACIAL RADIOFREQUENCY MICRONEEDLING PROCEDURES
May 25, 2022 08:45 ET | Colorescience
Carlsbad, CA, May 25, 2022 (GLOBE NEWSWIRE) -- In the midst of Skin Cancer Awareness Month, Colorescience®, a leading dermatologist-recommended specialty skincare and cosmetics company announces...
logo_no_tag_2c.jpg
Sientra To Present At The William Blair 42nd Annual Growth Stock Conference
May 23, 2022 09:00 ET | Sientra, Inc.
SANTA BARBARA, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), announced today its participation at the William Blair 42nd Annual Growth Stock...
Aesthetic Management Partners
Aesthetic Management Partners Announces Exclusive Distribution Agreement With Estar Medical
May 23, 2022 08:00 ET | Aesthetic Management Partners
CORDOVA, Tenn., May 23, 2022 (GLOBE NEWSWIRE) -- Estar Medical, the maker of Eclipse PRP® and Tropocells®, has signed an exclusive long-term marketing and distribution agreement with Aesthetic...